143 related articles for article (PubMed ID: 14648662)
1. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.
Cassia R; Moreno-Bueno G; Rodríguez-Perales S; Hardisson D; Cigudosa JC; Palacios J
J Pathol; 2003 Dec; 201(4):589-95. PubMed ID: 14648662
[TBL] [Abstract][Full Text] [Related]
2. CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
Nakayama K; Rahman MT; Rahman M; Nakamura K; Ishikawa M; Katagiri H; Sato E; Ishibashi T; Iida K; Ishikawa N; Kyo S
Int J Oncol; 2016 Feb; 48(2):506-16. PubMed ID: 26647729
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations associated with cyclin D1 overexpression in endometrial cancer.
Moreno-Bueno G; Rodríguez-Perales S; Sánchez-Estévez C; Marcos R; Hardisson D; Cigudosa JC; Palacios J
Int J Cancer; 2004 Jun; 110(2):194-200. PubMed ID: 15069681
[TBL] [Abstract][Full Text] [Related]
4. hCDC4 gene mutations in endometrial cancer.
Spruck CH; Strohmaier H; Sangfelt O; Müller HM; Hubalek M; Müller-Holzner E; Marth C; Widschwendter M; Reed SI
Cancer Res; 2002 Aug; 62(16):4535-9. PubMed ID: 12183400
[TBL] [Abstract][Full Text] [Related]
5. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
6. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.
Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI
Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.
Moreno-Bueno G; Sánchez-Estévez C; Cassia R; Rodríguez-Perales S; Díaz-Uriarte R; Domínguez O; Hardisson D; Andujar M; Prat J; Matias-Guiu X; Cigudosa JC; Palacios J
Cancer Res; 2003 Sep; 63(18):5697-702. PubMed ID: 14522886
[TBL] [Abstract][Full Text] [Related]
8. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.
Kwak EL; Moberg KH; Wahrer DC; Quinn JE; Gilmore PM; Graham CA; Hariharan IK; Harkin DP; Haber DA; Bell DW
Gynecol Oncol; 2005 Jul; 98(1):124-8. PubMed ID: 15913747
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the hCDC4 gene in gastric carcinomas.
Lee JW; Soung YH; Kim HJ; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
Eur J Cancer; 2006 Sep; 42(14):2369-73. PubMed ID: 16824748
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
Semczuk A; Marzec B; Skomra D; Roessner A; Cybulski M; Rechberger T; Schneider-Stock R
Oncology; 2005; 69(4):317-25. PubMed ID: 16293976
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.
Moreno-Bueno G; Hardisson D; Sarrió D; Sánchez C; Cassia R; Prat J; Herman JG; Esteller M; Matías-Guiu X; Palacios J
J Pathol; 2003 Apr; 199(4):471-8. PubMed ID: 12635138
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of hCDC4 can cause chromosomal instability.
Rajagopalan H; Jallepalli PV; Rago C; Velculescu VE; Kinzler KW; Vogelstein B; Lengauer C
Nature; 2004 Mar; 428(6978):77-81. PubMed ID: 14999283
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value and overexpression of cyclin A is correlated with gene amplification of both cyclin A and cyclin E in breast cancer patient.
Husdal A; Bukholm G; Bukholm IR
Cell Oncol; 2006; 28(3):107-16. PubMed ID: 16823179
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E dysregulation and chromosomal instability in endometrial cancer.
Hubalek MM; Widschwendter A; Erdel M; Gschwendtner A; Fiegl HM; Müller HM; Goebel G; Mueller-Holzner E; Marth C; Spruck CH; Reed SI; Widschwendter M
Oncogene; 2004 May; 23(23):4187-92. PubMed ID: 15048079
[TBL] [Abstract][Full Text] [Related]
16. hCDC4 variation in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Seto KK; Bell RS; Andrulis IL
Cancer Genet Cytogenet; 2006 Sep; 169(2):138-42. PubMed ID: 16938571
[TBL] [Abstract][Full Text] [Related]
17. Cyclin E overexpression and amplification in human tumours.
Schraml P; Bucher C; Bissig H; Nocito A; Haas P; Wilber K; Seelig S; Kononen J; Mihatsch MJ; Dirnhofer S; Sauter G
J Pathol; 2003 Jul; 200(3):375-82. PubMed ID: 12845634
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms.
van Drogen F; Sangfelt O; Malyukova A; Matskova L; Yeh E; Means AR; Reed SI
Mol Cell; 2006 Jul; 23(1):37-48. PubMed ID: 16818231
[TBL] [Abstract][Full Text] [Related]
19. Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer.
Noske A; Brandt S; Valtcheva N; Wagner U; Zhong Q; Bellini E; Fink D; Obermann EC; Moch H; Wild PJ
Oncotarget; 2017 Feb; 8(9):14794-14805. PubMed ID: 27582547
[TBL] [Abstract][Full Text] [Related]
20. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
Inoue M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]